No label defined (Q32153)
Jump to navigation
Jump to search
No description defined
- Discontinuation of Gender-Affirming Medical Treatments: Prevalence and Associated Features in a Nonprobabilistic Sample of Transgender and Gender-Diverse Adolescents and Young Adults in Canada and the United States.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
No description defined |
|
Statements
This study investigated the prevalence, correlates, and reasons for discontinuing gender-affirming medical treatment (GAMT) among transgender and gender-diverse adolescents and young adults living in Canada and the United States of America. (English)
PURPOSE (English)
Copyright © 2024 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved. (English)
2024
This exploratory study used data from an online survey of sexual and gender minority adolescents and young adults aged 15-29 years living in Canada or the United States of America (March-August 2022). (English)
METHODS (English)
Copyright © 2024 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved. (English)
2024
The analytic sample was constituted by participants who responded to questions regarding starting and stopping GAMT, as well as reasons for stopping. (English)
METHODS (English)
Copyright © 2024 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved. (English)
2024
Correlates of discontinuing GAMT were assessed using univariate logistic regression. (English)
METHODS (English)
Copyright © 2024 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved. (English)
2024
The mean age of the analytic sample (N = 3,937) was 21.1 years. (English)
RESULTS (English)
Copyright © 2024 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved. (English)
2024
Participants were predominantly nonbinary (54.2%) and assigned female at birth (80.8%). (English)
RESULTS (English)
Copyright © 2024 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved. (English)
2024
75.5% lived in Canada and 24.5% in the United States of America. (English)
RESULTS (English)
Copyright © 2024 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved. (English)
2024
Among those who had started GAMT, 121 of 720 (16.8%) reported having ever discontinued treatment. (English)
RESULTS (English)
Copyright © 2024 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved. (English)
2024
Forty five of 121 (37.2%) who ceased GAMT reported "Yes, but I wish I hadn't." (English)
RESULTS (English)
Copyright © 2024 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved. (English)
2024
The most frequently endorsed reasons for discontinuing GAMT were health reasons (37.3%), a change in gender identity (32.0%), and cost (16.0%). (English)
RESULTS (English)
Copyright © 2024 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved. (English)
2024
Greater age; nonbinary identity, 'other' gender identity; diagnosis of or self-identifying as living with schizophrenia; residing in the United States of America (relative to Canada); and endorsing a current Christian identity were associated with discontinuation. (English)
RESULTS (English)
Copyright © 2024 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved. (English)
2024
Ninety seven of 121 (80.2%) who discontinued GAMT reported a current transgender or gender-diverse identity. (English)
RESULTS (English)
Copyright © 2024 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved. (English)
2024
Given the dearth of information about the subpopulation who discontinue GAMT, this study advances candidate factors to inform future longitudinal research to better understand the multiple reasons and contexts for stopping GAMT. (English)
DISCUSSION (English)
Copyright © 2024 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved. (English)
2024
Kinnon R (English)
MacKinnon (English)
KR
Thiyaana (English)
Jeyabalan (English)
T
John F (English)
Strang (English)
JF
Jorge Andrés (English)
Delgado-Ron (English)
JA
Wren A (English)
Gould (English)
WA
Alex (English)
Cooper (English)
A
18 September 2024
18 September 2024